Movement Alert｜INNOCARE Rises 5.01% in Regular Trading, Biotechnology Sector Recovery Drives Rebound

Market Focus

Oct 06

On October 6, INNOCARE rose 5.01% in regular trading, trading at 14.03 HKD/share, with Turnover of 16.3466 million HKD.

The biotechnology sector broadly rebounded, with CANSINOBIO up 12.98%, AKESO up 4.43%, 3SBIO up 2.90%, INNOVENT BIO up 2.21%, and BEONE MEDICINES up 0.46%. This marks a recovery in sector sentiment following recent declines. INNOCARE had disclosed that major shareholder Sunland BioMed Ltd reduced holdings by 5 million shares, lowering its stake from 7.23% to 6.94%; this negative factor had largely been absorbed in prior trading sessions. Meanwhile, the company's 3.35 billion USD research collaboration and licensing agreement with Eli Lilly continues to provide fundamental support, sustaining elevated market attention.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1106900427"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1106900427\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1106900427?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-06 13:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1106900427","market":"hk","top_or_hot":-1,"title":"Movement Alert｜INNOCARE Rises 5.01% in Regular Trading, Biotechnology Sector Recovery Drives Rebound","media":"Market Focus","content":"<p><p>On October 6, INNOCARE rose 5.01% in regular trading, trading at 14.03 HKD/share, with Turnover of 16.3466 million HKD.</p><p>The biotechnology sector broadly rebounded, with CANSINOBIO up 12.98%, AKESO up 4.43%, 3SBIO up 2.90%, INNOVENT BIO up 2.21%, and BEONE MEDICINES up 0.46%. This marks a recovery in sector sentiment following recent declines. INNOCARE had disclosed that major shareholder Sunland BioMed Ltd reduced holdings by 5 million shares, lowering its stake from 7.23% to 6.94%; this negative factor had largely been absorbed in prior trading sessions. Meanwhile, the company's 3.35 billion USD research collaboration and licensing agreement with Eli Lilly continues to provide fundamental support, sustaining elevated market attention.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜INNOCARE Rises 5.01% in Regular Trading, Biotechnology Sector Recovery Drives Rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜INNOCARE Rises 5.01% in Regular Trading, Biotechnology Sector Recovery Drives Rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-06 13:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 6, INNOCARE rose 5.01% in regular trading, trading at 14.03 HKD/share, with Turnover of 16.3466 million HKD.</p><p>The biotechnology sector broadly rebounded, with CANSINOBIO up 12.98%, AKESO up 4.43%, 3SBIO up 2.90%, INNOVENT BIO up 2.21%, and BEONE MEDICINES up 0.46%. This marks a recovery in sector sentiment following recent declines. INNOCARE had disclosed that major shareholder Sunland BioMed Ltd reduced holdings by 5 million shares, lowering its stake from 7.23% to 6.94%; this negative factor had largely been absorbed in prior trading sessions. Meanwhile, the company's 3.35 billion USD research collaboration and licensing agreement with Eli Lilly continues to provide fundamental support, sustaining elevated market attention.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09969","symbol_name":"诺诚健华","start_time":0,"source_url":"","article_id":"1106900427","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1106900427","pubTimestamp":1791266156,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 6, INNOCARE rose 5.01% in regular trading, trading at 14.03 HKD/share, with Turnover of 16.3466 million HKD.The biotechnology sector broadly rebounded, with CANSINOBIO up 12.98%, AKESO up...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09969":"诺诚健华"},"translate_title":"走势提醒|诺诚健华常规交易上涨5.01%，生物科技板块复苏带动反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09969":1},"content_text":"On October 6, INNOCARE rose 5.01% in regular trading, trading at 14.03 HKD/share, with Turnover of 16.3466 million HKD.The biotechnology sector broadly rebounded, with CANSINOBIO up 12.98%, AKESO up 4.43%, 3SBIO up 2.90%, INNOVENT BIO up 2.21%, and BEONE MEDICINES up 0.46%. This marks a recovery in sector sentiment following recent declines. INNOCARE had disclosed that major shareholder Sunland BioMed Ltd reduced holdings by 5 million shares, lowering its stake from 7.23% to 6.94%; this negative factor had largely been absorbed in prior trading sessions. Meanwhile, the company's 3.35 billion USD research collaboration and licensing agreement with Eli Lilly continues to provide fundamental support, sustaining elevated market attention.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}